The antibody-based pharmaceuticals resource library’s Podcast

This episode focuses on the biology of natural killer (NK) cells and their function for application in tumor therapy.

This episode focuses on the mechanisms of immunosuppression by regulatory T cells, including direct and indirect mechanisms.

This episode focuses on the regulatory T cell expansion as an attractive option to suppress the development of graft-versus-host disease.

This episode focuses on the application of regulatory T cells for the prevention and treatment of graft-versus-host disease.

Cancer vaccines are designed to stimulate anti-tumor immunity through active immunization with tumor antigens and has long been envisioned as a key tool of effective cancer immunotherapy. Today we will go through the history, formulations, mechanisms of action, and clinical status of cancer vaccines. Creative Biolabs has been effectively supporting the cancer vaccine industry with our one-stop solutions for cancer vaccine discovery and development. We will accommodate the specific properties and clinical purpose of your vaccine candidate, and take careful scientific considerations to ensure the most appropriate solutions to develop your projects.

Today, we will explore the protac technology applied in tumor-targeted therapy. The following will be presented to you, such as a brief introduction to Protac, the mechanism of action, the advantages and disadvantages of protac as a drug, and the core content: the application of protac technology in tumor therapy. And the last part, the protac solutions provided by Creative Biolabs. If you have any questions about the PROCT development, please email us.

Due to the limitations and shortages of traditional cancer treatments, immunotherapy has become the most promising cancer treatment. Various cancer immunotherapy strategies have emerged. These include adoptive cellular immunotherapy, tumor vaccines, antibodies, immune checkpoint inhibitors, and small molecule inhibitors. Although most of these strategies are not meant to target macrophages directly or originally, macrophages contribute significantly to the final outcomes.

As a CRO company, Creative Biolabs offers first-in-class macrophage therapeutic development services. Please don’t hesitate to contact us if you are interested in our services or if you have any questions.

Creative Biolabs has archived professional academic reports and the latest scientific progress of lipid-based drug delivery, by making it into a podcast column. 

Creative Biolabs has archived professional academic reports and the latest scientific progress of lipid-based drug delivery, by making it into a podcast column. 

Creative Biolabs has archived professional academic reports and the latest scientific progress of lipid-based drug delivery, by making it into a podcast column.